Search Results - drugs%2fpharma+-+hiv%2fcancer%2fother

4 Results Sort By:
Myocardial In Vitro Platform for Drug Development and Cardiotoxicity Screening
This myocardial in vitro screening platform provides relevant physiological stimuli enabling analysis of output metrics with direct clinical relevance to cardiac function. While drug discovery is robust and well-funded, a very low percentage of experimental drug candidates reach the marketplace as FDA-approved therapies. This translates into billions...
Published: 2/11/2022   |   Inventor(s): William Richardson, Samuel Coeyman, Jonathan Heywood
Keywords(s): Analytical/Diagnostics/Instru./Sensors-Medical/Biological, Biomaterials - Cardiovascular, Cardiovascular, Diabetes, Drugs/Pharma - Antibiotics, Drugs/Pharma - Drug Delivery, Drugs/Pharma - HIV/Cancer/Other, Medical Device, Molecular Therapies, Oncology/Cancer, Regenerative Medicine, Tissue Engineering
Category(s): Biomedical Sciences
HIV Inhibitors to Prevent Spread of Virus in Patients
This inhibitor comprises a new strategy for mitigating the growth and spread of HIV. According to the World Health Organization, over 36 million people are living with HIV around the world. Consequently, the global HIV therapeutics market is estimated to reach a value of $15.3 billion by 2023. Most HIV inhibitors currently available are nucleoside or...
Published: 8/18/2016   |   Inventor(s): Dev P. Arya
Keywords(s): Drugs/Pharma - HIV/Cancer/Other
Category(s): Biomedical Sciences
Peptide for Improved Neural Stem Cell Growth
This peptide introduces a new way to accelerate cell growth of neural stem cells in culture. The global stem cell market is expected to grow from $6.7 billion in 2016 to nearly $12.3 billion in 2021, representing a thriving market. Cultured cells, especially stem cells, struggle to effectively proliferate on their own. Currently, peptide chains such...
Published: 7/12/2016   |   Inventor(s): Xiaowei Li, Ning Zhang, Xuejun Wen
Keywords(s): Biomaterials - Neurology, Drugs/Pharma - HIV/Cancer/Other, Regenerative Medicine
Category(s): Biomedical Sciences
Novel Screening Model for Adverse Drug Reactions
The U.S. FDA Adverse Events Reporting System (FAERS) has reported steady, exponential increases in both serious patient outcomes and mortality over the last decade (Figure 1). Adverse drug reactions present a unique challenge because human drug metabolism varies dramatically among individuals, and animal models are not always predictive of human response...
Published: 12/11/2009   |   Inventor(s): William Baldwin
Keywords(s): Analytical/Diagnostics/Instru./Sensors-Medical/Biological, Drugs/Pharma - HIV/Cancer/Other
Category(s): Biotechnology
© 2022. All Rights Reserved. Powered by Inteum